Zoono Group Limited (AU:ZNO) has released an update.
Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Zoono Group Limited announced the successful passage of all resolutions at its recent Annual General Meeting, with over 75% shareholder approval for the 2024 remuneration report. The company avoided a ‘second strike’ under the Corporations Act, ensuring stability in its governance structure. This biotech firm, known for its innovative antimicrobial solutions, continues to strengthen its market position with global regulatory approvals.
For further insights into AU:ZNO stock, check out TipRanks’ Stock Analysis page.